Towards more specific therapy for leukemia: terminal transferase as a therapeutic target.
Bulger
K
K
Evans Memorial Department of Clinical Research, Boston University Medical Center, MA 02118.
McCaffrey
R
R
D000970:Antineoplastic Agents / Q000494:pharmacology*; D002460:Cell Line; D004253:DNA Nucleotidylexotransferase / Q000037:antagonists & inhibitors / Q000502:physiology*; D016048:Dideoxyadenosine / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000627:therapeutic use; D015195:Drug Design; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000201:enzymology
D000970:Antineoplastic Agents; D016048:Dideoxyadenosine; D004253:DNA Nucleotidylexotransferase